Compare GEHC & AXON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEHC | AXON |
|---|---|---|
| Founded | 1892 | 1993 |
| Country | United States | United States |
| Employees | N/A | 6300 |
| Industry | Computer Software: Prepackaged Software | Ordnance And Accessories |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1B | 33.7B |
| IPO Year | 2022 | 2001 |
| Metric | GEHC | AXON |
|---|---|---|
| Price | $71.49 | $420.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 21 |
| Target Price | $82.70 | ★ $690.68 |
| AVG Volume (30 Days) | ★ 3.1M | 938.6K |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.22% | N/A |
| EPS Growth | ★ 4.84 | N/A |
| EPS | 0.85 | ★ 2.41 |
| Revenue | ★ $20,625,000,000.00 | $2,779,536,000.00 |
| Revenue This Year | $5.32 | $33.30 |
| Revenue Next Year | $4.60 | $29.33 |
| P/E Ratio | ★ $83.79 | $171.40 |
| Revenue Growth | 4.84 | ★ 33.47 |
| 52 Week Low | $58.75 | $339.01 |
| 52 Week High | $89.77 | $764.02 |
| Indicator | GEHC | AXON |
|---|---|---|
| Relative Strength Index (RSI) | 64.80 | 46.89 |
| Support Level | $68.88 | $402.98 |
| Resistance Level | $72.77 | $438.97 |
| Average True Range (ATR) | 1.71 | 17.65 |
| MACD | 0.59 | 4.99 |
| Stochastic Oscillator | 97.19 | 87.59 |
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Axon was founded in 1993, but its roots trace back to the invention of the Taser in 1974 by Jack Cover. Over the decades, Axon has expanded its product suite to include police body-worn cameras, a cloud-based evidence repository, AI-driven report-drafting software, drones and counter-drone sensors, and 911 dispatching software. The firm sells its products to end markets such as local and federal law enforcement, enterprise, corrections, and healthcare. It derives around four-fifths of its revenue from the US, with the remainder from international countries.